Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE, CEREW) -END
Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement, […]
Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE, CEREW) -END Read More »